Ghost Tree Capital Group

Ghost Tree Capital Group is an alternative investment firm based in Irvine, California, and New York that provides private credit, distressed debt, and healthcare-focused equity strategies. The firm targets non-traditional borrowers and niche retailers outside conventional banking frameworks while managing capital for institutional investors, registered investment advisers, family offices, and endowments. Operating with a dedicated team of six employees, the firm currently manages approximately $600 million in assets across its active funds and has successfully completed 45 transactions. The organization is backed by anchor investor Corient and holds equity positions in major public healthcare corporations, including Gilead Sciences and Bristol-Myers Squibb. The group traces its origins to the 2013 launch of its hedge fund by David Kim, followed by the 2021 establishment of its private credit arm by Mark Fox, Scott Warner, and Jeff Willardson.